Stock listing

A2H7JK Stock Price, News, Filings & Events — Telix Pharmaceuticals Limited

Selected listing: A2H7JK · LSX · EUR · DE

A2H7JK:LSX represents Telix Pharmaceuticals Limited, a biopharmaceutical company focused on developing and commercializing innovative cancer therapies. The company is advancing its pipeline of targeted radiopharmaceuticals, with recent news highlighting progress in clinical trials and regulatory filings. Investors can stay informed about upcoming events and market developments that may impact Telix's growth and strategic direction. The company's commitment to addressing unmet medical needs in oncology positions it as a key player in the biopharmaceutical landscape.